ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402
College Hill (media enquiries)
Holly Griffiths, sue
Charles, John McIntyre
Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation
... show that we can successfully eliminate irradiation by optimizing chemotherapy."
Other authors of this paper include Deqing Pei, John Sandlund, sue
Kaste, Raul Ribeiro, Jeffrey Rubnitz, Susana Raimondi, Mihaela Onciu, Elaine Coustan-Smith, Larry Kun, Sima Jeha, Cheng Cheng, Scott Howard, Vickey Si...
Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research
...atie Couric; Noreen Fraser, founder of the Noreen Fraser Foundation (NFF) and a cancer survivor; EIF Vice President Kathleen Lobb; Rusty Robertson and sue
Schwartz of the Robertson Schwartz Agency; and nonprofit executive Ellen Ziffren. Representatives of 24 patient advocacy groups are members of SU2C's...
Winning the War on Cancer: The Critical Role of Radiation Oncology
... cancer or relieve pain and other cancer symptoms.
The Capitol Hill briefing, hosted in coordination with the House Cancer Caucus, featured Rep. sue
Myrick (R-NC), a breast cancer survivor who was treated with radiation therapy, and Rep. Parker Griffith (D-AL), who this month became the first radia...
Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
...rom our earlier lead
investor, MPM Capital, allows us to continue the development of recombinant
alpha-one antitrypsin for hereditary emphysema," said sue
Arriva Pharmaceuticals. "With a committed, experienced management team, we
are now focused on the clinical development of our lead and p...
PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal
...e in the SEC filings for PPD, copies of
which are available free of charge upon request from the PPD investor
relations department. Contacts Media: sue
Ann Pentecost +919 456 5890 email@example.com
Analysts/Investors: Steve Smith +910 558 7585 firstname.lastname@example.org
Benitec MOU With CalbaTech, Inc.
that have come from a mother that has HIV. Those cords are currently
excluded from collection by cord blood companies. CONTACT:
MacLeman Rudi Michelson Chief Executive Officer Monsoon Communications +61 437 211 200 ...